Cited by 54Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementGynecological conditions and treatments

Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium

Gomes, M.K.O., Rosa-e-Silva, J.C., Garcia, S.B., de Sa Rosa-e-Silva, A.C. J., Turatti, A., Vieira, C.S., Ferriani, R.A.·2009·Human Reproduction

Abstract

BACKGROUND: The objectives of this study were: (i) to evaluate the effects of the levonorgestrel-releasing intrauterine system (LNG-IUS) on both proliferation and apoptosis markers and hormone receptors of the eutopic and ectopic endometrium of women experiencing pain related to endometriosis and (ii) to compare the results with those obtained with GnRH agonist (GnRHa) injections. METHODS: Pre- and post-treatment endometrium and endometriosis specimens were obtained from 22 women experiencing pain related to endometriosis who were treated with LNG-IUS (n = 11) or GnRHa (n = 11) for 6 months. Changes in the expression of proliferating cell nuclear antigen, Fas, progesterone receptor (PRA) and estrogen receptor alpha (ER-alpha) were analyzed by immunohistochemistry. RESULTS: The cell proliferation index was significantly reduced in the epithelium and stroma of both the eutopic and the ectopic endometrium after treatment with the LNG-IUS and GnRHa. Only LNG-IUS users showed an increased H-score for Fas in the epithelium of the eutopic and ectopic endometrium (P < 0.05). Expression of ER-alpha and PRA by the glandular epithelium was lower in the eutopic endometrium after both treatments, but this reduction was noted in the ectopic endometrium only after LNG-IUS treatments (P < 0.05). No difference was detected between groups for any of the markers. CONCLUSIONS: LNG-IUS reduced both cell proliferation and the expression of PRA and ER-alpha and increased Fas expression in the eutopic and ectopic endometrium of patients with endometriosis. Some of these actions were not observed with GnRHa.

Integrity signals

Registry

Crossref · 10.1093/humrep/dep288

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The ameliorative effects of LNG-IUS on endometriosis symptoms are likely modulated through a decrease in expression of glandular and stromal estrogen (α and β) and progesterone receptors in the ectopic endometrium.

    “Moreover, the ameliorative effects of LNG-IUS on endometriosis' symptoms are likely modulated through a decrease in the expression of glandular and stromal estrogen ( α and β ) and progesterone receptors in the ectopic endometrium [76, 77].”
  • LNG-IUS increases Fas expression in both eutopic and ectopic endometrium of patients with endometriosis.

    “In addition, LNG-IUS increased Fas expression in both eutopic and ectopic endometrium of patients with endometriosis [76].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Gomes, M. K. O., Rosa-e-Silva, J. C., Garcia, S. B., de Sa Rosa-e-Silva, A. C. J., Turatti, A., Vieira, C. S., & Ferriani, R. A.
Affiliations
Universidade de São Paulo (BR)
Venue
Human Reproduction
Published
2009-08-06
Volume
24
Issue
11
Pages
2736-2745
ISSN
  • 0268-1161 (ISSN-L)
  • 1460-2350
OpenAlex
W2033897915
Cited by
54
References
50
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2021: 3 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 3
FWCI
5.91
Type
journal article
Language
en
Open access
closed
Locations
  • Human Reproduction (publishedVersion)
  • PubMed (publishedVersion)
Funders
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
Keywords
levonorgestrel-releasing intrauterine system, endometriosis, GnRH agonist, cell proliferation, apoptosis, Fas expression, progesterone receptor, estrogen receptor alpha, eutopic endometrium, ectopic endometrium, proliferating cell nuclear antigen, endometriosis-associated pain
MeSH terms
Adolescent, Adult, Endometriosis, Endometrium, Female, Humans, Gonadotropin-Releasing Hormone, Pain, Receptors, Progesterone, Levonorgestrel, Apoptosis, fas Receptor, Estrogen Receptor alpha, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review